In a significant ruling, the Commonwealth Court of Pennsylvania has upheld the Pennsylvania Parole Board's decision to deny Walter Earl Allen, II credit for time spent on parole. The court found that Allen's recent DUI conviction, which involved the use of marijuana, justified the Board's decision. This ruling has implications for other parolees who may be using medical marijuana while on parole.

The case, W.E. Allen, II v. PPB, was filed under docket number 234 C.D. 2025. It highlights the intersection of criminal law and medical marijuana use, raising questions about the rights of individuals on parole who are also medical marijuana patients.

Walter Earl Allen, II, the petitioner, is a repeat offender with a history of driving under the influence (DUI). He was initially convicted of robbery and criminal conspiracy in 2004 and served a lengthy prison sentence. After being granted parole in 2010, Allen faced multiple challenges, including a recommitment as a convicted parole violator following two DUI convictions in 2018. His most recent DUI offense occurred on October 26, 2022, when he was arrested for driving under the influence of marijuana.

After his arrest, Allen was charged with several DUI-related offenses, marking his third DUI conviction. He later pled guilty and was sentenced to 21 to 84 months in county jail. After serving part of his sentence, he was returned to the Department of Corrections on August 7, 2024. The Pennsylvania Parole Board subsequently issued an order denying him credit for the time he spent on parole, citing unresolved drug and alcohol issues.

Allen appealed the Board's decision, arguing that his status as a medical marijuana patient should protect him from penalties related to his marijuana use. He contended that the Board's reasoning for denying him credit was not supported by the record, as he maintained that he had not tested positive for any other substances.

The Board responded, asserting that Allen's DUI conviction was sufficient evidence to deny him credit for his time spent on parole. They argued that his status as a medical marijuana patient did not shield him from the consequences of driving under the influence.

In its ruling, the court, led by President Judge Renée Cohn Jubelirer, affirmed the Board's decision. The court stated, "The Board's reasons must accurately reflect the facts informing its decision." The court found that Allen's conviction for driving under the influence of a controlled substance was a valid reason for the Board to deny him credit for street time.

The court emphasized that Allen's use of medical marijuana did not provide immunity from prosecution for DUI. The ruling clarified that while the Medical Marijuana Act protects patients from certain penalties, it does not protect them from the consequences of illegal actions, such as driving under the influence.

This ruling is significant as it reinforces the authority of the Pennsylvania Parole Board to deny parole credit based on a parolee's criminal behavior, even if that behavior involves the use of a substance that is legal for medical purposes. The court noted that Allen's history of DUI offenses and his continued illegal behavior while on parole justified the Board's decision.

Moving forward, this ruling may set a precedent for how medical marijuana use is treated in the context of parole violations. It underscores the importance of responsible behavior for individuals on parole, especially those who are using substances that may impair their ability to drive safely.

As for Allen, he has the option to appeal the court's decision to a higher court if he chooses. However, details regarding any potential related cases were not available in the court filing.